IP Library › Assignment 057116/0336
Patent Assignment
Reel/Frame 057116/0336

Assignment of Assignor's Interest

Recorded: 2021-08-08 Pages: 26
Assignor
NEURMEDIX, INC.
Executed: 2020-01-25
Assignee
NEURMEDIX, LLC
2120 COLORADO AVE, #230, SANTA MONICA, CALIFORNIA, 90404
Covered Properties (165)
Receptor Modulator Screening Methods
Application: 61/775,086 →
Screening Method for Therapeutic Antiinflammatory Agents
Application: 61/672,162 →
Treatment of Ocular Diseases
Application: 61/668,294 →
Steroid Tetrol Solid State Forms
Application: 61/424,173 →
Steroid Tetrol Solid State Forms-2
Application: 61/424,156 →
Methods and Compounds for Preparing 3ALPHA-Oxygen Substituted Steroids
Application: 61/423,457 →
Anticancer compounds and screening method - 3
Application: 61/266,483 →
Anticancer compounds and screening method - 2
Application: 61/266,416 →
Anticancer compounds and screening method
Application: 61/266,291 →
Anticancer compounds and screening method
Application: 61/266,092 →
Anticancer compounds and screening method
Application: 61/265,294 →
Patient subpopulations and treatment methods
Application: 61/186,360 →
Patient subpopulations and treatment methods
Application: 61/184,283 →
Metabolic disease surrogate biomarkers and uses - 3
Application: 61/162,620 →
Metabolic disease surrogate biomarkers and uses - 2
Application: 61/100,246 →
Metabolic disease surrogate biomarkers and uses
Application: 61/099,880 →
Crystalline and Amorphous Pharmaceuticals-2
Application: 61/093,694 →
Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related Compounds
Application: 61/059,658 →
Crystalline and Amorphous Pharmaceuticals
Application: 61/042,240 →
Crystalline and Amorphous Pharmaceuticals
Application: 61/026,472 →
Efficacy stabilized therapeutic compositions
Application: 60/965,730 →
Clinical Workflow and System Interface Design for Automatic End-Diastolic and End-Systolic Image Selection in Angiographic Left Ventricular Analysis
Application: 60/981,222 →
T Cell Modulation Methods
Application: 60/888,058 →
Metabolic Disease Treatments
Application: 60/885,003 →
Drugs and Uses
Application: 60/868,042 →
Biodynamic Drugs and Uses
Application: 60/866,700 →
T Cell Modulation Methods
Application: 60/866,395 →
Inflammation treatment method
Application: 60/843,112 →
Metabolic Disease Treatments
Application: 60/829,848 →
Modulation of Inflammation
Application: 60/825,569 →
Inflammation Treatment Method 2
Application: 60/825,564 →
Inflammation treatment method
Application: 60/793,792 →
Steroid sparing method
Application: 60/628,252 →
Treatment methods and surrogate markers
Application: 60/615,307 →
Steroid analogs, assay methods and treatment methods
Application: 60/614,869 →
Screening methods for immune modulators I
Application: 60/408,332 →
Immune dysregulation treatment method
Application: 60/407,146 →
Immune modulation method using steroid compounds
Application: 60/343,523 →
Immune modulation method using steroid compounds
Application: 60/340,054 →
Immune modulation method using steroid compounds
Application: 60/338,015 →
Immune modulation method using steroid compounds
Application: 60/323,016 →
Ergosteroids IV: synthesis and biological activity of steroid glucuronosides, ethers and alkylcarbonates
Application: 60/272,624 →
Pharmaceutical compositions and treatment methods
Application: 60/190,140 →
Pharmaceutical Compositions and Treatment Methods
Application: 60/166,116 →
Pharmaceutical Compositions and Treatment Methods
Application: 60/157,347 →
Pharmaceutical Compositions and Treatment Methods
Application: 60/157,275 →
Methods of Treating and/or Reducing the Likelihood of Viral Infection, Bacterial Infection, Parasite Infection, Fungal Infection, and Compositions and Formulations for Use in Such Methods
Application: 60/145,823 →
Methods of Treating and/or Reducing the Likelihood of Viral Infection Bacterial Infection, Parasitic Infection, Bone Marrow Rejection, Organ Rejection, Compromised Immune System in the Elderly and Other Conditions, and Formulations for Use in Such Methods
Application: 60/142,386 →
Methods of Treating and/or Reducing the Likelihood of Viral Infection, Bacterial Infection, Toxoplasmosis, Cryptosporidiosis, Malaria, Aftican Trypanosomoiasis, American Trypanosomiasis, Bone Marrow Rejection, Organ Rejection, Compromised Immune System in the El
Application: 60/137,745 →
Pharmaceutical Compositions and Treatment Methods
Application: 60/124,087 →
Cytokine Combination Therapy
Application: 60/112,206 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in Treatment of Toxoplasmosis and/or in Treatment of Cryptosporidiosis
Application: 60/110,127 →
Treatment Methods Using Pharmaceutical Solid State Forms
Patent: 9,877,972 →
Application: 14/459,493 →
Publication: US US20160175322A9
Steroids Having 7-Oxygen and 17-Heteroaryl Substitution-3
Patent: 9,115,168 →
Application: 14/027,842 →
Publication: US US20140018337A1
Steroids Having 7-Oxygen and 17-Heteroaryl Substitution-2
Patent: 9,102,702 →
Application: 14/027,825 →
Publication: US US20140018336A1
Treatment Methods Using Pharmaceutical Solid State Forms
Application: 13/919,728 →
Publication: US US20130338125A1
Methods of Preparing Pharmaceutical Solid State Forms
Patent: 9,314,471 →
Application: 13/919,593 →
Publication: US US20130345455A1
Pharmaceutical Solid State Forms-2
Application: 13/919,386 →
Publication: US US20130345184A1
Treatment of Ocular Diseases
Application: 13/835,995 →
Publication: US US20140010806A1
Drug Identification Method
Application: 13/734,147 →
Publication: US US20130164780A1
Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related Compounds-2
Patent: 9,163,059 →
Application: 13/664,304 →
Publication: US US20130066087A1
Treatment Methods Using Pharmaceutical Solid State Forms
Application: 13/563,996 →
Publication: US US20120302537A1
Crystalline Anhydrate Forms of a Pharmaceutical
Application: 13/563,982 →
Publication: US US20120296105A1
Steroid Tetrol Solid State Forms - 2
Application: 13/328,760 →
Publication: US US20120252774A1
Steroid Tetrol Solid State Forms
Application: 13/328,374 →
Publication: US US20120220560A1
Methods and Compounds for Preparing 3ALPHA-Oxygen Substituted Steroids
Application: 13/327,701 →
Publication: US US20120214987A1
Steroid Compounds and Treatment Methods
Patent: 8,367,646 →
Application: 13/306,141 →
Publication: US US20120071454A1
Screening and Treatment Method
Application: 13/252,846 →
Publication: US US20120029260A1
11-Aza, 11-Thia and 11-Oxa Sterol Compounds and Compositions
Patent: 8,541,600 →
Application: 13/183,275 →
Publication: US US20120041016A1
15-Thia Steroid Compounds and Compositions
Application: 13/107,573 →
Publication: US US20120101052A9
Steroids Having 7-Oxgen and 17-Heteroaryl Substitution
Patent: 8,569,275 →
Application: 13/095,528 →
Publication: US US20110212935A1
Unsaturated Steroid Compounds
Patent: 8,586,770 →
Application: 13/030,326 →
Publication: US US20110137057A1
Drug Product and Process for Making
Application: 12/968,028 →
Publication: US US20110085984A1
Steroid Compounds and Formulations
Patent: 8,076,316 →
Application: 12/957,661 →
Publication: US US20110098260A1
Anticancer Compounds and Screening Method
Application: 12/957,273 →
Publication: US US20110129423A1
Unsaturated Steroid Compounds
Application: 12/905,778 →
Publication: US US20110028711A1
Cancer Treatment Methods
Patent: 7,906,497 →
Application: 12/792,942 →
Publication: US US20100240633A1
Patient populations and treatment methods
Application: 12/732,164 →
Publication: US US20100227841A1
Patient populations and treatment methods
Application: 12/731,692 →
Publication: US US20100222315A1
Pharmaceutical Compositions-4
Patent: 8,106,036 →
Application: 12/634,455 →
Publication: US US20100222313A1
15-Oxa-Steroid Compunds
Patent: 7,947,846 →
Application: 12/633,721 →
Publication: US US20100222425A1
Compounds and Compositions
Patent: 8,022,234 →
Application: 12/571,060 →
Publication: US US20110009372A1
Patient populations and treatment methods
Application: 12/566,565 →
Publication: US US20100075937A1
Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related Compounds
Patent: 8,309,746 →
Application: 12/479,626 →
Publication: US US20090326251A1
Solid State Forms of a Pharmaceutical
Patent: 8,252,947 →
Application: 12/418,559 →
Publication: US US20090291933A1
Diene and Triene Compounds and Formulations
Patent: 7,842,680 →
Application: 12/406,033 →
Publication: US US20090181936A1
Diene Compounds and Formulations
Patent: 7,638,509 →
Application: 12/405,970 →
Publication: US US20090176752A1
Pharmaceutical Solid State Forms
Patent: 8,518,922 →
Application: 12/370,510 →
Publication: US US20090291932A1
Steroid Tetrol Solid State Forms
Patent: 8,486,926 →
Application: 12/272,767 →
Publication: US US20090143349A1
Stabilized Therapeutic Compositions and Formulations
Application: 12/196,271 →
Publication: US US20090258850A1
Drug Identification and Treatment Method
Application: 11/942,689 →
Publication: US US20080153792A1
Drug Screening and Treatment Methods
Patent: 8,217,025 →
Application: 11/942,664 →
Publication: US US20080146532A1
Drug Identification and Treatment Method
Patent: 8,354,396 →
Application: 11/941,936 →
Publication: US US20080153797A1
Drug Screen and Treatment Method
Application: 11/941,934 →
Publication: US US20080221074A1
Prostate Cancer Treatment
Patent: 7,550,450 →
Application: 11/862,153 →
Publication: US US20080070881A1
Steroids Having 1,8-Unsaturation and Formulations Comprising Same
Patent: 7,514,420 →
Application: 11/838,154 →
Publication: US US20080004250A1
Prostate Cancer Treatment
Patent: 7,462,610 →
Application: 11/837,508 →
Publication: US US20080009472A1
Breast and Prostate Cancer Treatment Method
Patent: 7,863,261 →
Application: 11/835,397 →
Publication: US US20080176823A1
Prostate and Breast Cancer Treatment
Patent: 7,696,189 →
Application: 11/835,394 →
Formulations
Patent: 7,691,835 →
Application: 11/835,367 →
Publication: US US20080058301A1
Pharmaceutical Compositions
Patent: 7,776,845 →
Application: 11/835,334 →
Publication: US US20080021006A1
Metabolic Disease Treatments
Application: 11/696,637 →
Publication: US US20080015174A1
Therapeutic Treatment Methods
Patent: 7,547,687 →
Application: 11/674,128 →
Publication: US US20070275938A1
Therapeutic Treatment Methods
Patent: 7,482,334 →
Application: 11/674,126 →
Publication: US US20070275937A1
Formulations and Treatment Methods
Application: 11/564,026 →
Publication: US US20070275936A1
Pharmaceutical Compositions 3
Patent: 7,723,532 →
Application: 11/552,095 →
Publication: US US20080176824A1
Pharmaceutical Compositions
Application: 11/551,202 →
Publication: US US20080045490A1
Pharmaceutical Compositions - 2
Application: 11/551,195 →
Publication: US US20090215737A1
Sepsis Treatment Methods
Patent: 7,935,839 →
Application: 11/549,875 →
Publication: US US20070213309A1
Asthma Treatment Methods
Application: 11/549,825 →
Publication: US US20070265236A1
Disease treatment methods
Application: 11/549,615 →
Publication: US US20080085873A1
Pharmaceutical compositions
Application: 11/549,606 →
Publication: US US20070203107A1
Cystic Fibrosis Treatment Methods
Patent: 7,910,571 →
Application: 11/549,580 →
Publication: US US20080090791A1
Surrogate markers
Application: 11/389,319 →
Publication: US US20070077203A1
Stem Cell Expansion and Uses
Patent: 7,910,755 →
Application: 11/389,294 →
Publication: US US20070077201A1
Drug product and process for making
Application: 11/355,561 →
Publication: US US20070053832A1
Treatment screening methods
Application: 11/242,547 →
Publication: US US20060088473A1
Treatment screening methods
Application: 11/241,678 →
Publication: US US20060073099A1
Steroid analogs and characterization and treatment methods
Application: 11/241,670 →
Publication: US US20070014719A1
Compositions and treatment methods
Application: 11/234,675 →
Publication: US US20060079492A1
Neurological disorder treatment methods
Application: 10/949,782 →
Publication: US US20050075321A1
Pharmaceutical compositions and treatment methods - 8
Application: 10/890,490 →
Publication: US US20050159366A1
Pharmaceutical treatments and compositions
Application: 10/877,911 →
Publication: US US20070129282A1
Pharmaceutical compositions and treatment methods-7
Application: 10/876,957 →
Publication: US US20050282732A1
Antiandrogens with marginal agonist activity and methods of use
Application: 10/814,503 →
Publication: US US20040242618A1
Pharmaceutical compositions and treatment methods-6
Application: 10/741,929 →
Publication: US US20040220161A1
Therapeutic treatment methods 2
Application: 10/728,400 →
Publication: US US20050101581A1
Therapeutic treatment methods
Application: 10/651,515 →
Publication: US US20040138187A1
Pharmaceutical compositions and treatment methods - 4
Application: 10/607,035 →
Publication: US US20040097406A1
Pharmaceutical compositions and treatment methods
Application: 10/602,330 →
Publication: US US20040220114A1
Therapeutic treatment methods
Application: 10/526,321 →
Pharmaceutical compositions and treatment methods
Application: 10/329,065 →
Publication: US US20040116359A1
Pharmaceutical Compositions and Treatment Methods
Patent: 7,396,827 →
Application: 10/319,356 →
Publication: US US20040043973A1
Blood cell deficiency treatment method
Application: 10/087,929 →
Publication: US US20030083231A1
Immune modulation method using steroid compounds
Application: 09/820,483 →
Publication: US US20030060425A1
Therapeutic treatments for blood cell deficiencies
Application: 09/675,470 →
Therapeutic treatment of androgen receptor driven conditions
Application: 09/675,323 →
Infection treatment compositions and methods
Application: 09/586,673 →
Treatment methods using formulations comprising micronized and non-micronized compounds
Application: 09/586,672 →
Pharmaceutical Compositions and Treatment Methods
Patent: 6,667,299 →
Application: 09/535,675 →
Awning extension and retraction mechanism
Patent: 6,276,424 →
Application: 09/519,779 →
Cytokine combination therapy
Application: 09/461,026 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in the Treament of Hepatitis C Virus and Other Togaviruses
Application: 09/449,184 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in Treatment of Toxoplasmosis and in the Treatment of Cryptosporidiosis
Application: 09/449,042 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in the Treatment of Malaria and the Treatment of African and American Trypansomias
Application: 09/449,004 →
Process for Effecting Allylic Oxidation Using Dicarboxylic Acid Imides and Chromium Reagents
Patent: 6,384,251 →
Application: 09/423,467 →
DELTA5-Androstenes Useful for Promoting Weight Maintenance or Weight Loss and Treatment Process
Patent: 5,424,463 →
Application: 08/327,843 →
DELTA5-Androstenes Useful for Promoting Weight Maintenance or Weight Loss and Treatment Process
Application: 08/123,151 →
Treatment Process for Promoting Weight Loss Employing a Substituted DELTA5-Androstene
Application: 07/575,156 →
Agents for the Arrest and Theraoy of Retroviral Infections
Patent: 4,956,355 →
Application: 07/182,480 →
Pharmaceutical Formulation and Therapeutic Method for Treatment of Viral Infections
Application: 07/090,637 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in Treatment of Malaria, Treatment of African Trypanosomiasis and Treatment of American Trypanosomiasis as Well as Other Indications and Infections
Application: 60/109,923 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in Treatment of Hepatitis C and Other Togaviruses
Application: 60/109,924 →
Immune Response Modulation Methods
Application: 60/164,048 →
Pharmaceutical Compositions and Treatment Methods
Application: 60/126,056 →
Tetrol Steroids and Esters
Patent: 7,524,835 →
Application: 10/607,415 →
Publication: US US20060063749A1
Esters of Tetrahydroxy Steroids
Application: 10/949,694 →
Publication: US US20050256095A1
Pharmaceutical Compositions and Treatment Methods
Application: 09/414,905 →
Compound Screening Method
Application: 60/140,028 →
Treatment methods for immune disregulation conditions including immune senescence
Application: 60/257,071 →
Compounds useful for treating hypertriglyceridemia
Application: 10/408,466 →
Publication: US US20040019026A1
Use of dhea analogs for treating hypertriglyceridemia
Application: 60/238,659 →
Antiandrogens with marginal agonist activity and methods of use therefore
Application: 60/459,450 →
7-Hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof
Application: 10/427,280 →
Publication: US US20040034003A1
Crystalline Anhydrate Forms Of A Pharmaceutical
Patent: 9,555,046 →
Application: 14/459,528 →
Publication: US US20160083415A1
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 18, 2008
From: WHITE, STEVEN K; GE, YU; HUANG, YUJIN; OLSON, ERIN
To: HOLLIS-EDEN PHARMACEUTICALS, INC.
Reel/Frame 021258/0184 →
Change of Name Mar 11, 2010
From: HOLLIS-EDEN PHARMACEUTICALS, INC.
To: HARBOR BIOSCIENCES, INC.
Reel/Frame 024066/0325 →
Assignment of Assignor's Interest Mar 4, 2011
From: GE, YU; WHITE, STEVEN K.; HUANG, YUJIN
To: HARBOR BIOSCIENCES, INC.
Reel/Frame 025902/0134 →
Change of Name Nov 2, 2012
From: HARBOR BIOSCIENCES, INC.
To: HARBOR DIVERSIFIED, INC.
Reel/Frame 029227/0929 →
Assignment of Assignor's Interest Nov 8, 2013
From: CASTELLINO, ANGELO J.; WHITE, STEVEN K.; READING, CHRISTOPHER L.
To: HARBOR THERAPEUTICS, INC.
Reel/Frame 031567/0194 →
Assignment of Assignor's Interest Feb 25, 2015
From: RESERVA LLC
To: NEURMEDIX INC.
Reel/Frame 035026/0292 →
Assignment of Assignor's Interest Feb 25, 2015
From: RESERVA LLC
To: NEURMEDIX, INC.
Reel/Frame 035030/0541 →
Assignment of Assignor's Interest Jul 10, 2015
From: HARBOR DIVERSIFIED, INC.
To: HARBOR THERAPEUTICS, INC.
Reel/Frame 036057/0392 →
Assignment of Assignor's Interest Feb 2, 2016
From: STICKNEY, DWIGHT; WHITE, STEVEN K; OLSON, ERIN; LIAW, WEI-CHENG
To: HARBOR BIOSCIENCES, INC.
Reel/Frame 037644/0398 →
Assignment of Assignor's Interest Feb 2, 2016
From: HARBOR DIVERSIFIED, INC .
To: HARBOR THERAPEUTICS, INC.
Reel/Frame 037645/0078 →
Merger and Change of Name Feb 2, 2016
From: HARBOR BIOSCIENCES, INC.; HARBOR DIVERSIFIED, INC .
To: HARBOR DIVERSIFIED, INC .
Reel/Frame 037644/0908 →
Change of Name Feb 2, 2016
From: HOLLIS-EDEN PHARMACEUTICALS, INC.
To: HARBOR BIOSCIENCES, INC.
Reel/Frame 037644/0669 →
Assignment of Assignor's Interest Feb 2, 2016
From: HARBOR THERAPEUTICS, INC.
To: RESERVA LLC
Reel/Frame 037681/0395 →
Assignment of Assignor's Interest Feb 2, 2016
From: RESERVA LLC
To: NEURMEDIX, INC.
Reel/Frame 037681/0522 →
Assignment of Assignor's Interest Apr 27, 2017
From: HARBOR DIVERSIFIED, INC.
To: HARBOR THERAPEUTICS, INC.
Reel/Frame 042161/0893 →
Assignment of Assignor's Interest Aug 8, 2021
From: NEURMEDIX, INC.
To: BIOVIE INC.
Reel/Frame 057116/0451 →
Assignment of Assignor's Interest Aug 8, 2021
From: NEURMEDIX, LLC
To: NEURMEDIX, INC.
Reel/Frame 057116/0362 →